BioAge Labs, Inc. (BIOA)

NASDAQ: BIOA · Real-Time Price · USD
5.14
+0.10 (1.98%)
At close: Jan 17, 2025, 4:00 PM
4.892
-0.250 (-4.83%)
After-hours: Jan 17, 2025, 5:26 PM EST
1.98%
Market Cap 184.26M
Revenue (ttm) n/a
Net Income (ttm) -70.94M
Shares Out 35.85M
EPS (ttm) -33.13
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 210,723
Open 5.11
Previous Close 5.04
Day's Range 4.97 - 5.18
52-Week Range 3.85 - 26.62
Beta n/a
Analysts Hold
Price Target 18.00 (+250.2%)
Earnings Date Feb 15, 2025

About BIOA

BioAge Labs, Inc. is a clinical-stage biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. The company’s technology platform and differentiated human datasets allows users to identify targets based on insights into molecular changes that drive aging. Its product includes azelaprag, an orally available small molecule that is in phase 1 clinical trial for the treatment of obesity; and initiated phase 2 clinical trial of azelaprag in combination with tirzepatide for the treatment of obesity in older adults... [Read more]

Sector Healthcare
IPO Date Sep 26, 2024
Employees 56
Stock Exchange NASDAQ
Ticker Symbol BIOA
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

Analyst Forecast

According to 3 analysts, the average rating for BIOA stock is "Hold." The 12-month stock price forecast is $18.0, which is an increase of 250.20% from the latest price.

Price Target
$18.0
(250.20% upside)
Analyst Consensus: Hold
Stock Forecasts

News

BioAge Labs, Inc. Is Being Sued For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESS Newswire / January 20, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces the firm has filed a class action lawsuit against BioAge Labs, Inc....

5 hours ago - Accesswire

BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit

NEW YORK , Jan. 20, 2025 /PRNewswire/ --  Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of stock of BioAge Labs, Inc. (NASDAQ: BIOA) pursuant and/or traceable to the regis...

6 hours ago - PRNewsWire

The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against BioAge Labs, Inc.

LOS ANGELES, CA / ACCESS Newswire / January 19, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces the firm has filed a class action lawsuit against BioAge Labs, Inc....

1 day ago - Accesswire

BioAge Labs, Inc. Is Being Sued For Securities Law Violations And Affected Investors Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESS Newswire / January 18, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces the firm has filed a class action lawsuit against BioAge Labs, Inc....

2 days ago - Accesswire

BIOA COURT NEWS: BioAge Labs Sued for Misrepresentations in IPO Documents - Investors that Lost Money are Urged to Contact BFA Law before March 10 Deadline

NEW YORK CITY, NY / ACCESS Newswire / January 16, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against BioAge Labs, Inc. (NASDAQ:BIOA) and cert...

4 days ago - Accesswire

BioAge Labs Inc. Is Being Sued For Securities Law Violations And Affected Investors Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESS Newswire / January 16, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces the firm has filed a class action lawsuit against BioAge Labs, Inc....

4 days ago - Accesswire

BioAge Labs, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before March 10, 2025 to Discuss Your Rights - BIOA

NEW YORK , Jan. 16, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of BioAge Labs, Inc. (NASDAQ: BIOA). Shareholders who purchased shares of BIOA during the class ...

4 days ago - PRNewsWire

BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit

NEW YORK , Jan. 15, 2025 /PRNewswire/ --  Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of stock of BioAge Labs, Inc. (NASDAQ: BIOA) pursuant and/or traceable to BioAge's ...

4 days ago - PRNewsWire

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioAge Labs

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In BioAge To Contact Him Directly To Discuss Their Options If you suff...

5 days ago - PRNewsWire

Deadline Approaching: BioAge Labs, Inc. (BIOA) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming March 10, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who pu...

6 days ago - Business Wire

BioAge Labs Inc Is Being Sued For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces the firm has filed a class action lawsuit against BioAge Labs, Inc. ("BioAge" or "the Company") (NASDAQ:BIOA) for violatio...

6 days ago - Accesswire

BioAge Labs Inc Is Being Investigated For Securities Law Violations And The Schall Law Firm Urges Affected Shareholders To Reach Out

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of BioAge Labs, Inc. ("BioAge" or "the Company") (NASDAQ:BIOA) for ...

7 days ago - Accesswire

Novartis And BioAge Team Up To Develop Aging Therapies And Boost Investor Potential

BioAge Labs and Novartis have formed a strategic partnership to discover age-related therapies, providing BioAge with crucial validation and funding amid Azelaprag's clinical trial failure. Despite Bi...

Other symbols: NVS
7 days ago - Seeking Alpha

Investors With Losses Are Invited To Join The Schall Law Firm In An Inquiry Into BioAge Labs, Inc. For Securities Fraud

LOS ANGELES, CA / ACCESSWIRE / January 12, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of BioAge Labs, I...

8 days ago - Accesswire

BioAge Labs Inc. Is Being Investigated For Securities Law Violations And The Schall Law Firm Urges Affected Shareholders To Reach Out

LOS ANGELES, CA / ACCESSWIRE / January 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of BioAge Labs, I...

10 days ago - Accesswire

BioAge Labs, Inc. (BIOA) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of BioAge Labs, Inc. (“BioAge” or the “Company”) (NASDAQ: BIOA) investors concerning the Company's p...

11 days ago - Business Wire

Securities Fraud Investigation Into BioAge Labs, Inc. (BIOA) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of (“BioAge” or the “Company...

11 days ago - Business Wire

Securities Fraud Investigation Into BioAge Labs, Inc. (BIOA) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of BioAge Labs, Inc. (“BioAge” or the “Company”) (NASDAQ: BIOA) on behalf of investors concerning the Company'...

11 days ago - Business Wire

BIOA LEGAL DEADLINE: Why was BioAge Labs Sued? Investors are Urged to Contact BFA Law before March 10 Court Deadline

NEW YORK, NY / ACCESSWIRE / January 8, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against BioAge Labs, Inc. (NASDAQ:BIOA) and certain of its ...

12 days ago - Accesswire

Rosen Law Firm Urges BioAge Labs, Inc. (NASDAQ: BIOA) Stockholders to Contact the Firm for Information About Their Rights

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of stock of BioAge Labs, Inc. (NASDAQ: BIOA) pur...

12 days ago - Business Wire

BIOA INVESTOR NOTICE: BioAge Labs Investors are Notified of Ongoing Investigation – Contact BFA Law if You Lost Money (NASDAQ:BIOA)

NEW YORK, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into BioAge Labs, Inc. (NASDAQ: BIOA) for potential violations of the fede...

13 days ago - GlobeNewsWire

BIOA INVESTOR NEWS: BioAge Labs is Under Investigation - Contact BFA Law if You Lost Money on Your Investment

NEW YORK, NY / ACCESSWIRE / January 6, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into BioAge Labs, Inc. (NASDAQ:BIOA) for potential violations of the fed...

14 days ago - Accesswire

BioAge Labs Inc Is Being Investigated For Securities Law Violations And The Schall Law Firm Encourages Affected Shareholders To Reach Out

LOS ANGELES, CA / ACCESSWIRE / January 4, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of BioAge Labs, In...

16 days ago - Accesswire

BioAge Labs (BIOA) Shares Plummet After Discontinuing Trial Just 2 Months After IPO- Hagens Berman

SAN FRANCISCO , Jan. 3, 2025 /PRNewswire/ -- Shares of BioAge (NASDAQ: BIOA) have plummeted since the company's December 6 announcement of the discontinuation of a Phase 2 trial for its weight-loss dr...

17 days ago - PRNewsWire